WALTHAM, Mass., May 14, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Dr. Mary Lynne Hedley, president of TESARO, will present at the UBS 2014 Global Healthcare Conference on Wednesday, May 21, 2014 at 8:00 a.m. Eastern time at the Sheraton New York Times Square Hotel.
A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company's website for 14 days after the conference.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: For further information, please contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations 1.781.325.1116 email@example.com